Biobytes

LEADERSHIP & RESEARCH TEAM

Connecting Medicine, Data, and AI

Biobytes brings together physicians who understand the challenges of clinical practice

and leading bioinformatics and AI experts who decode the language of life through data.

Jung-Woo Lee CEO & Founder

“For the many patients I see with sarcopenia,I want to use data and technology to endthe suffering caused by the lack of treatment.”

Welcome. I am Jung-Woo Lee, CEO of Biobytes.

As an orthopedic surgeon, I have seen that sarcopenia is more than a consequence of aging: it poses a serious threat to older adults' health. Yet there was no innovative drug anywhere in the world to address its underlying causes.

We believed the answer lay in data. Biobytes established M-Bank, the world's first multicenter sarcopenia cohort, and uses a proprietary multi-omics AI engine to identify the biomarkers underlying the disease.

Our technology reaches beyond the laboratory. From diagnostic support AI and tailored health supplements that improve quality of life today to the discovery of first-in-class drug targets, we are working toward healthier aging. We invite you to follow and support Biobytes on this journey.

Jung-Woo Lee

CEO & Founder

PhD in Medicine / Orthopedic Surgeon

Jung-Woo Lee's signature

Core Leadership

Leadership bringing together clinical medicine, advanced AI, and bioinformatics

Jungwoo Lee

Jungwoo Lee

CEO/CSO

  • Ph.D. in Medicine (Orthopedic Surgery)
  • Orthopedic Surgeon (Sarcopenia Specialist)
  • Associate Professor of Orthopedic Surgery, Wonju Severance Christian Hospital, Yonsei University
  • Director, Korean Sarcopenia Society
  • Member, Global Leadership Initiative in Sarcopenia (GLIS) | One of 5 in Korea
  • Certified Sports Medicine Specialist
Jaewon Kim

Jaewon Kim

VP/CTO

  • Master's Degree, Korea University Graduate School
  • Head of Clinical Trials, Pfizer Korea
  • Head of AI Development, LifeSemantics Inc. (KOSDAQ-listed)
  • Head of AI Drug Development & Technology Transfer, Basgenbio Inc.
  • Researcher, Institute of Evidence-based Medicine, Korea University College of Medicine
  • Steering Committee Member for Bio Big Data, Korea Biotechnology Industry Organization
  • Advisor on AI Drug Development, Chemical & Bio Industry Skills Council (ISC)
  • Specialized Instructor in AI Drug Development, Korea National Enterprise for Clinical Trials (KoNECT)
Sol Lee

Sol Lee

Research Director / CDO

  • Ph.D. in Aging Epidemiology (Korea Univ.)
  • Director of Genetic Epidemiology Research Lab at Basgenbio (Exit)
  • New Health Technology Assessment Center at NECA
  • Late-phase Clinical Data Analysis at Pfizer
  • Nanoori Hospital, Clinical Research Center at Wooridul Hospital
  • Visiting Researcher, Institute for Health Promotion, Yonsei University

Research & Business Team

Core teams connecting data collection to drug pipeline development

AI Drug Discovery Team

AI Drug Development Division

Deok-Young Kwon · Hyo-Seon Hong · Chan-Joong Lee · Ji-Woo Kim

Drug development, bioinformatics (BI) analysis, AI modeling, and CADD-based discovery of drug biomarkers and hit compounds

Biobank Team

Biobank Division

Hye-Yeon Shin · Ji-Young Kim · Hyo-Jin Jeon

Builds multicenter cohorts with Wonju Severance, Kangbuk Samsung, and Seoul St. Mary's hospitals, and collects and manages blood, muscle tissue, and clinical data

Regulatory & Management Team

Regulatory Affairs & Management Division

Yu-Ra Kim · Hye-Ji Kim · Chae-Min Lee

Regulatory approvals for medical devices and health functional foods (GMP, ISO 13485), government R&D programs, and finance and management

Sales & Marketing Team

Pharma Sales, Planning & Marketing Division

Hoon-Woong Chun · Dong-Jun Kim

Hospital and B2B partnership sales, health functional food distribution, and planning and digital marketing